Growing Involvement of Public and Private Entities to Treat Lymphedema To Favor The Growth Opportunities of Lymphedema Treatment Market in India During 2022-2030

According to our new research study on "India Lymphedema Treatment Market Size and Forecast (2020-2030), Country Share, Trend, and Growth Opportunity Analysis - by Condition Type, Treatment Type, and End User," the market is expected to grow from US$ 926.65 million in 2022 to US$ 1,511.06 million by 2030; it is estimated to record a cagr of 6.3% from 2022 to 2030. 

Lymphedema refers to tissue swelling caused by an accumulation of protein-rich fluid, which is drained through the body's lymphatic system. It most commonly affects the arms or legs but can also occur in the chest wall, abdomen, neck, and genitals. Lymph nodes are an essential part of the lymphatic system. Lymphedema is largely caused due to the consequence of several cancer treatments. These include prostate, head and neck, and pelvic cancers such as those in bladder, testicles, ovaries, uterus, or cervix, along with lymphoma and melanoma. The swelling may occur on the part of the body that is treated. For instance, treating tumors in the belly or pelvis via radiation or surgery may cause swelling in the groin, genitals, belly, and one or both legs. Swelling in the face, eyes, or mouth can be caused by treatment for head & neck cancer.

Various government organizations and companies operating in the lymphedema market constantly focus on strategic developments such as collaborations, expansions, agreements, partnerships, and product launches. These help them improve their sales, expand their geographic reach, and enhance their capacities to cater to a greater than existing customer base. A few of the noteworthy developments in the lymphedema market are mentioned below:

On July 16, 2021, Sakra World Hospital launched a 'Comprehensive Lymphedema Care Centre' on the occasion of World Plastic Surgery. This newly launched center will be equipped with the latest technologies in diagnostics and offer treatment by a team of internationally certified lymphedema specialists, including plastic surgeons, physiotherapists, occupational therapists, clinical psychologists, and clinical nutritionists. Sakra Comprehensive Lymphedema Care Centre will offer services such as ICG-based real-time lymphedema scan, lymphovenous bypass surgery (LVA), lymph node transfer surgery, lymphedema reduction surgery and conservative treatment (Lymphedema rehabilitation).

In November 2021, Anatomech, a Pune-based start-up, launched Kue, a brand of compression socks. The sales rose steadily as soon as it was launched, indicating a heavy demand. Anatomech is developing a daily-wear, portable sleeve that enables continuous lymphatic decongestion for 10-12 hours for patients suffering from lymphedema-a surgical consequence that follows mastectomy or other aggressive surgeries.

The socks, which enhance oxygen delivery and muscle recovery while reducing spasms and cramps in the legs, are a part of the wearable technology products that Anatomech has been working on since 2020. In September, Anatomech was one of the runners-up at the Pune round of the TiE Women's Global Pitch Competition, which featured 58 women-initiated companies.

As per a news published in Open Digest on September 2023, the Institute of Applied Dermatology (IAD) in Kerala is exploring a tie-up with Indian start-ups to make cost-effective compression bandages to make lymphedema and lymphatic filariasis treatment more affordable for millions of patients, which are a key element in treatment. The compression bandages used for the treatment are considerably expensive. India has all the required natural resources, such as latex and cotton, to make compression bandages but still has to depend heavily on global suppliers for quality compression bandages. Thus, IAD is ready to collaborate with tech start-ups for necessary guidance to develop compression bandages.

Such developments in lymphedema treatment by Indian companies are expected to offer lucrative opportunities to the market. 

India Lymphedema Treatment Market, By Condition Type

Based on condition type, the global lymphedema treatment market is segmented into primary lymphedema and secondary lymphedema. The secondary lymphedema segment held the largest market share in 2022. The primary lymphedema segment is anticipated to register a higher CAGR during 2022-2030. Secondary lymphedema's significant market share is usually attributed to cancer-related treatment, which is a prominent cause of secondary lymphedema.

By condition type, the india lymphedema treatment market is expected to be led by the secondary lymphedema segment.

Primary lymphedema is a rare chronic pathology associated with constitutional abnormalities of the lymphatic system. For instance, the Frontiers S.A. report states that primary lymphedema can appear at age 35 and is also referred to as lymphedema tarda. Additionally, the incidence of primary lymphedema is low, affecting 1 in 100,000 people worldwide. Primary lymphedema is also strongly linked to acquired lymphedema and has genetic mutations causing primary lymphedema. For example, breast cancer patients carrying acquired lymphedema have higher genetic variation, called single nucleotide polymorphisms (SNPs), in the same genes causing primary lymphedema. Such factors positively influence the overall growth of the segment during the analysis period.

Essity AB, Lympha Press USA Ltd, AIROS Medical Inc, 3M Co, Bio Compression Systems Inc, Lohmann & Rauscher GmbH & Co KG, Huntleigh Healthcare Ltd, Dynamic Techno Medicals Pvt Ltd, Medi GmbH & Co KG, Datt Mediproducts Pvt Ltd, Smith & Nephew Plc, SIGVARIS Management AG, and Tactile Systems Technology Inc. are among the leading companies operating in India lymphedema treatment market. 

Companies operating in the India lymphedema treatment market adopt various organic and inorganic strategies. Growth strategies mainly include product launches and approvals, mergers & acquisitions, collaborations, and partnerships, among the growth strategies witnessed in the India lymphedema treatment market. 

A few of the significant developments by key market players is listed below.

1.    KOB GmbH launched its two products at MEDICA Trade Fair 2022. With this 2-component system, the company expanded its product portfolio of compression bandages. VisioCompress2 Lite is used when a lower compression pressure is required. Like the proven VisioCompress2 multi-layer system, VisioCompress2 Lite consists of a padding and permanently elastic non-woven bandage.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com